MEDICAL VERIFICATION: DR. E. HARTMANN, MD (AESTHETIC MEDICINE) | CERTIFICATE: SK-0451122 | LICENSED PRACTITIONERS ONLY
Vellux™ 100UI Type A Botulinum Toxin
A lyophilized neuromodulator engineered via AEGEN Bio’s proprietary purification process. Delivers a 900kDa neurotoxin complex with a minimal protein load of 0.32ng/, securing a highly localized diffusion radius of 0.3mm to prevent adjacent muscle paresis.
Formulation Specifications
Active Substance
Clostridium Botulinum Toxin Type A (100 Units)
Excipients
Human Serum Albumin (0.5mg), Sodium Chloride (0.9mg)
Purity & Structure
99.8% Purity | 900kDa Macro-complex | pH 6.8
Clinical Efficacy
Onset: 48-72 hours | Peak: 14 days | Duration: 6-8 months
Reconstitution Protocol
Maintain cold chain storage at 2°C to 8°C prior to use. Do not freeze reconstituted solution.
Inject 2.5mL of unpreserved 0.9% Sodium Chloride Injection USP into the to achieve a concentration of 4.0 Units/0.1mL.
Gently rotate the. Do not agitate. Vacuum must draw the diluent into the automatically; discard if vacuum is absent.
Administer within 24 hours of reconstitution. Standard glabella complex dosage: 20 Units distributed across 5 intramuscular injection sites.
Contraindications & Safety
Strictly restricted to licensed medical practitioners.
Vellux™ is contraindicated in patients with known hypersensitivity to any botulinum toxin preparation or excipients. Do not administer in the presence of infection at proposed injection sites. Contraindicated for individuals with diagnosed neuromuscular disorders (e.g., Amyotrophic Lateral Sclerosis, Myasthenia Gravis, Lambert-Eaton syndrome) due to increased risk of clinically significant systemic effects, including severe dysphagia and respiratory compromise.

Reviews
There are no reviews yet.